Quick Answer
Tanke Biosciences Corp reported Operating Income of $4.53 million for fiscal year 2012.
Tanke Biosciences Corp Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2012 | $4.53M | +160.6% |
| 2011 | $1.74M | -60.2% |
| 2010 | $4.37M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2013 | -$530.3K | -124.3% | -454.3% |
| June 30, 2013 | $149.7K | -90.0% | +475.2% |
| March 31, 2013 | -$39.9K | -108.2% | -101.8% |
| September 30, 2012 | $2.18M | +81.3% | +45.8% |
| June 30, 2012 | $1.50M | — | +206.5% |
| March 31, 2012 | $488.5K | +168.3% | -59.4% |
| September 30, 2011 | $1.20M | — | +268.4% |
| March 31, 2011 | -$715.0K | — | — |
- Tanke Biosciences Corp showed an increase of +160.6% in Operating Income compared to the prior fiscal year.
- Over the 2010–2012 period, Tanke Biosciences Corp’s operating income has grown by 3.6% (from $4.37 million to $4.53 million).
- The most recent figure is from Tanke Biosciences Corp’s fiscal year 2012 report (Form 10-K), filed with the SEC on April 15, 2013.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: